DASH Trademark

Trademark Overview

On Wednesday, August 7, 2013, a trademark application was filed for DASH with the United States Patent and Trademark Office. The USPTO has given the DASH trademark a serial number of 86031675. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 3, 2016. This trademark is owned by Infinity Pharmaceuticals, Inc.. The DASH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting of clinical studies and trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials
dash

General Information

Serial Number86031675
Word MarkDASH
Filing DateWednesday, August 7, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 3, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 8, 2014

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting of clinical studies and trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 15, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInfinity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameInfinity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, October 3, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 3, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 8, 2016EXTENSION 3 GRANTED
Wednesday, March 2, 2016EXTENSION 3 FILED
Sunday, April 3, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 2, 2016TEAS EXTENSION RECEIVED
Wednesday, March 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2015EXTENSION 2 GRANTED
Wednesday, September 2, 2015EXTENSION 2 FILED
Monday, September 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 2, 2015TEAS EXTENSION RECEIVED
Wednesday, March 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2015EXTENSION 1 GRANTED
Monday, March 2, 2015EXTENSION 1 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Tuesday, September 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 8, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 18, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 30, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 29, 2014ASSIGNED TO LIE
Thursday, May 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 14, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 14, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 14, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 22, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 22, 2013NON-FINAL ACTION E-MAILED
Friday, November 22, 2013NON-FINAL ACTION WRITTEN
Wednesday, November 20, 2013ASSIGNED TO EXAMINER
Thursday, August 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 10, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

dash trials medical clinical research scientific information field providing pharmaceuticals studies